Li Yong, Tan Bi-bo, Fan Li-qiao, Zhao Qun, Liu Yu, Wang Dong
Department of General Surgery, the Fourth Affiliated Hospital, Hebei Medical University Shijiazhuang, China.
Hepatogastroenterology. 2010 Nov-Dec;57(104):1435-41.
BACKGROUND/AIMS: Little is known about the expression and significance of the proteins in regional lymph node metastases (LNMs) of gastric carcinoma (GC). In present study we intend to evaluate the expression of COX-2 and Survivin in primary tumors (PT) and LNMs of GC, keeping track of the correlation between the clinicopathologic factors, the tumor angiogenesis, patients' survival and prognosis.
Surgical specimens were obtained and paired from 65 patients with advanced GC. The gastric operational pieces have been examined with usual histological, histochemical and immunohistochemical staining. Then relationship and significance of these data were analyzed.
Expression of COX-2 was higher in LNMs than that in PT p < 0.05 with positive correlativity of COX-2 between PT and LNMs p < 0.01 and positive correlativity also existed between COX-2 and Survivin in PT p < 0.01. The patients with strong expression of COX-2 had lower cumulative survival rate than those with weaker COX-2 expressed (p < 0.01). In LNMs, strong expression of COX-2 was an independent prognostic factor for GC in PT and LNMs while strong expression of Survivin was not that case.
The expression of COX-2 in PT and LNMs explained for the heterogeneity of GC and it has a tight correlation with GC cell's apoptosis. Strong expression of COX-2 in LNMs was associated with poor prognosis for patients with GC.
背景/目的:关于胃癌区域淋巴结转移(LNMs)中蛋白质的表达及其意义所知甚少。在本研究中,我们旨在评估环氧化酶-2(COX-2)和生存素在胃癌原发肿瘤(PT)和区域淋巴结转移灶中的表达情况,追踪其与临床病理因素、肿瘤血管生成、患者生存及预后之间的相关性。
获取65例进展期胃癌患者的手术标本并配对。对胃手术标本进行常规组织学、组织化学及免疫组织化学染色检查。然后分析这些数据的关系及意义。
COX-2在区域淋巴结转移灶中的表达高于原发肿瘤(P<0.05),原发肿瘤与区域淋巴结转移灶中COX-2呈正相关(P<0.01),原发肿瘤中COX-2与生存素也呈正相关(P<0.01)。COX-2强表达患者的累积生存率低于COX-2弱表达患者(P<0.01)。在区域淋巴结转移灶中,COX-2强表达是胃癌原发肿瘤及区域淋巴结转移灶的独立预后因素,而生存素强表达则不然。
COX-2在原发肿瘤和区域淋巴结转移灶中的表达解释了胃癌的异质性,且与胃癌细胞凋亡密切相关。区域淋巴结转移灶中COX-2强表达与胃癌患者预后不良相关。